- In addition to correcting the fill, what is the most appropriate action for the technician to take?
Answer: Report the event as a near miss in the pharmacy's quality assurance system.
This is a classic example of a near miss. The error was caught before it reached the patient. Reporting it allows the pharmacy to track trends (e.g., frequent mix-ups between these two drugs) and implement preventative measures as part of its continuous quality improvement (CQI) program.
- Which of the following would be the most effective action plan resulting from this RCA?
Answer: Relocating the different strengths to separate, clearly marked areas of the pharmacy.
The most effective safety strategies involve system-level changes that make it difficult or impossible to make an error. Physically separating the different strengths of warfarin addresses the root cause identified in the analysis—the proximity of look-alike packaging. This is a much stronger intervention than relying on memory or passive warnings.
- How does documenting and analyzing near misses contribute to a pharmacy's Continuous Quality Improvement (CQI) program?
Answer: It helps identify system weaknesses and trends before they can cause patient harm.
Continuous Quality Improvement (CQI) is a proactive approach to improving safety and efficiency. Analyzing near-miss data allows the pharmacy team to identify patterns (e.g., errors at a certain time of day, with specific drugs) and implement targeted improvements before a patient is ever affected.
- Which statement about the Vaccine Adverse Event Reporting System (VAERS) is most accurate?
Answer: Reporting to VAERS is mandatory for certain adverse events following vaccination.
While anyone can submit a report to VAERS (including patients and caregivers), healthcare providers are required by law to report certain adverse events listed on the VAERS Table of Reportable Events Following Vaccination. VAERS is a surveillance system and a report does not by itself prove causation.
- A core principle of conducting a root-cause analysis (RCA) in a 'just culture' environment is that the process should focus on:
Answer: perfecting the system rather than blaming the individual.
The primary goal of an RCA is to understand how and why a system failed, allowing an error to occur. It operates on the principle that most errors are caused by flawed processes, not bad people. The focus is on fixing the system (e.g., workflow, technology, environment) to make it harder for anyone to make a similar mistake in the future.
- A pharmacy's continuous quality improvement (CQI) committee notes from error reports that several mistakes have involved confusion between hydroxyzine and hydralazine. Which of the following is an appropriate system-level intervention?
Answer: Affixing shelf labels with 'Tall Man' lettering (e.g., hydrOXYzine/hydrALAZINE) and separating the drugs in inventory.
CQI uses data from event reports to drive proactive, system-based changes. Using 'Tall Man' lettering and physically separating look-alike/sound-alike (LASA) drugs are evidence-based strategies to reduce the risk of confusion and prevent future errors. Simply telling staff to 'be more careful' is not an effective safety strategy.
- A patient tells a pharmacy technician that they think their new blood pressure medication is causing a persistent cough. What is the technician's most appropriate response?
Answer: Immediately notify the pharmacist and ask them to speak with the patient.
Pharmacy technicians cannot provide clinical advice or assess adverse effects. The technician's crucial role is to recognize the situation requires a pharmacist's intervention. They must alert the pharmacist, who can then properly counsel the patient and determine the necessary steps, which may include reporting the event.
- Which of the following best describes the primary purpose of the FDA's MedWatch program?
Answer: To allow for voluntary and mandatory reporting of serious adverse events and medication product problems.
The FDA's MedWatch program is a safety information and adverse event reporting system. Its primary purpose is to collect reports from healthcare professionals and consumers regarding serious adverse events, product quality problems, therapeutic failures, and medication errors to monitor the safety of medical products after they are approved.
- A patient informs the pharmacy staff that they were dispensed the wrong medication. After the pharmacist verifies the error, what is the immediate priority for the pharmacy team?
Answer: Assessing the patient's safety and addressing any immediate health concerns.
When a medication error has reached a patient, the first and most critical priority is the patient's well-being. The pharmacist must assess the situation, determine if the patient has taken the incorrect medication, and provide instructions to ensure their immediate safety. All other actions, like documentation and investigation, follow after the patient has been cared for.
- What is the primary goal of establishing a non-punitive event reporting system within a pharmacy?
Answer: To encourage staff to report all errors and near misses to improve patient safety.
A non-punitive or 'just culture' reporting system is designed to remove the fear of punishment for reporting errors. When staff feel safe reporting mistakes and near misses, the organization gains valuable data that can be used to identify system weaknesses and make improvements, ultimately creating a safer environment for patients.
- When documenting a medication error for internal review, which piece of information is most crucial for identifying contributing factors?
Answer: A detailed description of the circumstances when the error occurred.
To effectively learn from an error and prevent it from happening again, it is essential to understand the context. A detailed description of the circumstances (e.g., high prescription volume, an interruption, two look-alike drug bottles next to each other) provides the necessary information for a meaningful root-cause analysis.
- A pharmacist is notified that a patient taking lamotrigine has been hospitalized with a life-threatening rash, a known serious adverse effect. This event must be reported to the:
Answer: FDA MedWatch program.
Serious and unexpected adverse drug reactions, especially those resulting in hospitalization, are a key category of events that should be reported to the FDA's MedWatch program. This data helps the FDA monitor post-marketing safety and take action if needed, such as updating a drug's warning label.
- After the pharmacist addresses the issue with the patient, how should this event be categorized and documented internally?
Answer: As a medication error, because the wrong strength reached the patient.
This is a medication error because an incorrect dose was dispensed and reached the patient. Whether the patient experienced harm determines if it was also an adverse drug event, but it is fundamentally a medication error. It is not a near miss, as the error was not caught beforehand. It is not a sentinel event unless it resulted in death or serious harm.
- Which of the following events would be LEAST appropriate to report through the FDA MedWatch program?
Answer: A patient reports experiencing mild drowsiness while taking diphenhydramine.
The MedWatch program is intended for serious, unexpected, or novel adverse events and product quality issues. Mild drowsiness is a very common, expected, and well-documented side effect of diphenhydramine and does not meet the criteria for a MedWatch report.
- The pharmacy technician should recognize that this product quality concern should be reported by the pharmacist to which organization?
Answer: The FDA's MedWatch program
The FDA's MedWatch program is the appropriate channel for reporting product quality problems, such as suspected contamination, questionable stability, or defective components. An unusual odor suggests a potential product quality issue.
- What is the primary objective of conducting a root-cause analysis (RCA) after a significant medication error has occurred?
Answer: To identify underlying system flaws and process issues to prevent future errors.
A root-cause analysis is a systematic, non-punitive process designed to investigate why an error occurred, not just who was involved. Its goal is to uncover system-level vulnerabilities (e.g., poor lighting, similar packaging, understaffing, flawed workflow) and implement changes to prevent recurrence.
- In the context of pharmacy quality assurance, which scenario accurately describes a 'near miss'?
Answer: A technician selected the wrong medication but the error was caught by the pharmacist during verification.
A 'near miss' or 'close call' is a medication error that is detected and corrected before it reaches the patient. Reporting near misses is crucial for identifying and correcting system vulnerabilities before they can cause patient harm.
- A technician unpacks a tote from a drug wholesaler and finds a bottle of tablets that appears to have counterfeit labeling. What is the immediate, most appropriate action?
Answer: Quarantine the product, notify the pharmacist, and document the issue for reporting to the FDA.
Suspected counterfeit products represent a significant risk to public health. The product must be immediately isolated (quarantined) to prevent it from entering the patient supply chain. The pharmacist must be notified, and the issue should be documented and reported to the FDA, often through the MedWatch program, to alert the agency and protect other pharmacies.
- While preparing an IV admixture, a technician notices that a vial of sterile water for injection is cloudy. What is the most appropriate course of action?
Answer: Do not use the vial, quarantine it and others from the same lot, and report the product quality issue to the pharmacist.
Cloudiness in a solution intended to be clear indicates a serious product integrity problem, such as contamination or precipitation. The product must not be used. The vial and others from the same lot should be quarantined to prevent their use, and the issue must be reported to the pharmacist. The pharmacist would then report this to the manufacturer and likely the FDA MedWatch program.
- A patient reports experiencing a severe rash and shortness of breath minutes after receiving a shingles vaccine at the pharmacy. This event should be reported to which of the following?
Answer: The Vaccine Adverse Event Reporting System (VAERS)
The Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety surveillance program co-sponsored by the FDA and CDC. It is the designated system for reporting any clinically significant adverse events that occur after the administration of any vaccine licensed in the United States.
